|
This is an index of adverse event reports related to Megace ES (Megestrol). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (15)
Cases resulting in a serious event (15)
Cases resulting in death (6)
Cases resulting in life threatening events (1)
Cases resulting in hospitalization (4)
Cases resulting in other serious reactions (11)
Adverse event in male receiving Megace ES (Megestrol)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in male receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-16
Patient: male, weighing 92.2 kg (202.8 pounds)
Adverse reactions / side effects: Pneumomediastinum, Subcutaneous Emphysema, Pulmonary Embolism, Respiratory Distress, Pulmonary Fibrosis, Lung Consolidation, Bronchopleural Fistula, Aspiration, Interstitial Lung Disease, Pneumothorax, Areflexia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Megace ES (Megestrol)
Other drugs received by patient: Toprol-XL; Lipitor; Coumadin; Prevacid; Valtrex; Zestril; Hydrocortisone; Ketoconazole; Lumigan; Alphagan; Lupron; Folic Acid; Calcium
Adverse event in female receiving Megace ES (Megestrol)
Reported by a consumer/non-health professional from United States on 2007-10-16
Patient: female, weighing 49.4 kg (108.8 pounds)
Adverse reactions / side effects: Weight Decreased, Balance Disorder, Mouth Ulceration, NO Therapeutic Response, Fall, Loss of Consciousness
Suspect drug(s):
Megace ES
Dosage: 625 mg/5ml oral
Administration route: Oral
Indication: Cachexia
Start date: 2007-08-16
Megace ES
Dosage: 625 mg/5ml oral
Administration route: Oral
Indication: Neoplasm Malignant
Start date: 2007-08-16
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in female receiving Megace ES (Megestrol)
Reported by a physician from United States on 2007-05-07
Patient: female
Adverse reactions / side effects: Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-07
Patient:
Adverse reactions / side effects: Oedema Peripheral, Deep Vein Thrombosis
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in male receiving Megace ES (Megestrol)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-05
Patient: male
Adverse reactions / side effects: Oedema Peripheral, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: death
Suspect drug(s):
Megace ES (Megestrol)
Adverse event in 83 year old female receiving Megace ES (Megestrol)
Reported by a physician from United States on 2007-04-04
Patient: 83 year old female, weighing 60.9 kg (134.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Creatinine Renal Clearance Decreased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Hepatic Enzyme Increased, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Increased Appetite
Start date: 2007-01-01
End date: 2007-02-21
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Oral Intake Reduced
Start date: 2007-01-01
End date: 2007-02-21
Adverse event in 83 year old female receiving Megace ES (Megestrol)
Reported by a physician from United States on 2007-03-20
Patient: 83 year old female, weighing 60.9 kg (134.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Condition Aggravated, Blood Creatinine Increased, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Appetite Disorder
Start date: 2007-01-01
End date: 2007-02-21
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Oral Intake Reduced
Start date: 2007-01-01
End date: 2007-02-21
Other drugs received by patient: Progesterone; Iron Supplement; Atenolol
Adverse event in 83 year old female receiving Megace ES (Megestrol)
Reported by a pharmacist from United States on 2007-03-06
Patient: 83 year old female, weighing 60.9 kg (134.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Creatinine Renal Clearance Decreased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Increased Appetite
Start date: 2007-01-01
End date: 2007-02-21
Megace ES
Dosage: 625 mg qday po
Administration route: Oral
Indication: Oral Intake Reduced
Start date: 2007-01-01
End date: 2007-02-21
Other drugs received by patient: Progesterone; Iron Supplement; Atenolol
|
